Human osteoblasts express functional CXC chemokine receptors 3 and 5: Activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and β‐N‐acetylhexosaminidase release
- 19 November 2002
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 194 (1) , 71-79
- https://doi.org/10.1002/jcp.10188
Abstract
Osteoblasts (OBs) contribute to the maintenance of bone homeostasis and their activity can be influenced by immune cells localized in bone lacunae. We investigated the expression of the chemokine receptors in isolated human OBs by reverse transcriptase-polymerase chain reaction (RT-PCR) and flow cytometry, and report a novel finding, namely, that OBs express high levels of CXC chemokine receptor 3 (CXCR3) and 5 (CXCR5). Functional assays to evaluate CXCR3 and CXCR5 demonstrated that their ligands—CXCL10 and CXCL13, respectively—significantly induce the release of β-N-acetylhexosaminidase, an enzyme involved in endochondral ossification and bone remodeling able to degrade important extracellular matrix components. Alkaline phosphatase activity, a useful index of matrix formation was also up-regulated by CXCL10 and CXCL13. However, OB activation by these ligands does not affect OB proliferation. Both Bordetella pertussis toxin and neutralizing anti-CXCR3/anti-CXCR5 monoclonal antibodies block CXCL10 and CXCL13 induction, respectively. We also demonstrated the expression of CXCL10 and CXCL13 in human bone tissue biopsies. These results indicate that both CXCR3/CXCL10 and CXCR5/CXCL13 receptor–ligand pairs may play an important role in OB activity through the specific up-regulation of two enzymes, which are involved in the bone remodeling process. Moreover, our data suggest that OBs may play a role in the modulation of bone formation through the combined action of these two enzymes.Keywords
This publication has 48 references indexed in Scilit:
- Interactions between immune and bone cells: new insights with many remaining questionsJournal of Clinical Investigation, 2000
- Glycosaminoglycan Metabolism and Cytokine Release in Normal and Otosclerotic Human Bone Cells Interleukin-1 TreatedConnective Tissue Research, 1997
- Actions of the chemotactic cytokines MCP‐1, MCP‐2, MCP‐3, RANTES, MIP‐1α and MIP‐1β on human monocytesEuropean Journal of Immunology, 1995
- Mechanism of Bone TurnoverAnnals of Medicine, 1993
- Biochemical Markers of Bone MetabolismAnnals of Medicine, 1993
- Glucosaminidase, galactosaminidase, and glucuronidase in the growth plateJournal of Orthopaedic Research, 1990
- The architecture of bone marrow cell populationsThe International Journal of Cell Cloning, 1990
- Microcinematographic and autoradiographic kinetic studies of bone cell differentiation in vitro: Matrix formation and mineralizationBone, 1989
- Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).The Journal of Experimental Medicine, 1987
- γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteinsNature, 1985